Therapeutics
Professor J J McNeil
Objectives At the completion of this subject, students will have a sound understanding of methods used to critically evaluate the basis for current therapeutic decision making and how to incorporate future advances in knowledge into ongoing therapeutic practise; the process underlying the formulation of rational therapeutic policy including integration of epidemiological concepts, clinical trial data, clinical benefit versus intervention risk analysis and cost-benefit analysis; the development of a personal formulary; the operation of a clinical dosage adjustment program.
Synopsis Half-day seminars covering three levels of therapeutics knowledge. Firstly, issues recently resolved and for which world-wide consensus guidelines now exist (eg hypertension, primary and secondary prevention of coronary vascular disease). Secondly, issues which are rapidly changing and nearing consensus (eg peptic ulcer disease, chronic gastritis and gastric cancer). Thirdly, issues where there is inadequate information to make final policy but where challenging new information is available (eg osteoporosis, risk management in cervical and breast cancer, risk and cost-benefit of invasive treatment of cardiovascular disease).
Assessment Contribution to MED6003 MCQ * Continuous assessment: reports/presentations and class participation (satisfactory faculty requirement) including formulary presentation
| Published by Monash University, Clayton, Victoria
3168 Copyright © Monash University 1996 - All Rights Reserved - Caution Authorised by the Academic Registrar December 1996 |